These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 28139139)

  • 1. Roseburia spp.: a marker of health?
    Tamanai-Shacoori Z; Smida I; Bousarghin L; Loreal O; Meuric V; Fong SB; Bonnaure-Mallet M; Jolivet-Gougeon A
    Future Microbiol; 2017 Feb; 12():157-170. PubMed ID: 28139139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro.
    Scott KP; Martin JC; Duncan SH; Flint HJ
    FEMS Microbiol Ecol; 2014 Jan; 87(1):30-40. PubMed ID: 23909466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice.
    Neyrinck AM; Possemiers S; Verstraete W; De Backer F; Cani PD; Delzenne NM
    J Nutr Biochem; 2012 Jan; 23(1):51-9. PubMed ID: 21411304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota and type 2 diabetes mellitus.
    Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
    Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Nie K; Ma K; Luo W; Shen Z; Yang Z; Xiao M; Tong T; Yang Y; Wang X
    Front Cell Infect Microbiol; 2021; 11():757718. PubMed ID: 34881193
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro kinetics of prebiotic inulin-type fructan fermentation by butyrate-producing colon bacteria: implementation of online gas chromatography for quantitative analysis of carbon dioxide and hydrogen gas production.
    Falony G; Verschaeren A; De Bruycker F; De Preter V; Verbeke K; Leroy F; De Vuyst L
    Appl Environ Microbiol; 2009 Sep; 75(18):5884-92. PubMed ID: 19633122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiological role of host microbiota in the development of obesity.
    Kobyliak N; Virchenko O; Falalyeyeva T
    Nutr J; 2016 Apr; 15():43. PubMed ID: 27105827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Microbiome That Shapes Us: Can It Cause Obesity?
    Omer E; Atassi H
    Curr Gastroenterol Rep; 2017 Oct; 19(12):59. PubMed ID: 29080046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression.
    Jiang S; Xie S; Lv D; Zhang Y; Deng J; Zeng L; Chen Y
    Antonie Van Leeuwenhoek; 2016 Oct; 109(10):1389-96. PubMed ID: 27431681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential for enriching next-generation health-promoting gut bacteria through prebiotics and other dietary components.
    Lordan C; Thapa D; Ross RP; Cotter PD
    Gut Microbes; 2020; 11(1):1-20. PubMed ID: 31116628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity: Gut microbiota, host genetics and diet interact to affect the risk of developing obesity and the metabolic syndrome.
    Greenhill C
    Nat Rev Endocrinol; 2015 Nov; 11(11):630. PubMed ID: 26346953
    [No Abstract]   [Full Text] [Related]  

  • 13. Gut
    Precup G; Vodnar DC
    Br J Nutr; 2019 Jul; 122(2):131-140. PubMed ID: 30924428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A representative of the dominant human colonic Firmicutes, Roseburia faecis M72/1, forms a novel bacteriocin-like substance.
    Hatziioanou D; Mayer MJ; Duncan SH; Flint HJ; Narbad A
    Anaerobe; 2013 Oct; 23():5-8. PubMed ID: 23916720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediterranean diet: the missing link between gut microbiota and inflammatory diseases.
    Bifulco M
    Eur J Clin Nutr; 2015 Sep; 69(9):1078. PubMed ID: 26014263
    [No Abstract]   [Full Text] [Related]  

  • 16. The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation.
    Hiippala K; Jouhten H; Ronkainen A; Hartikainen A; Kainulainen V; Jalanka J; Satokari R
    Nutrients; 2018 Jul; 10(8):. PubMed ID: 30060606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome: The critters within.
    Gravitz L
    Nature; 2012 May; 485(7398):S12-3. PubMed ID: 22616099
    [No Abstract]   [Full Text] [Related]  

  • 18. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
    Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
    Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Talking microbes: When gut bacteria interact with diet and host organs.
    Cani PD; Everard A
    Mol Nutr Food Res; 2016 Jan; 60(1):58-66. PubMed ID: 26178924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbes: possible link between modern lifestyle transition and the rise of metabolic syndrome.
    Moossavi S; Bishehsari F
    Obes Rev; 2019 Mar; 20(3):407-419. PubMed ID: 30548384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.